Clinical trial
Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis
NCT06853145 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis
- Lead sponsor
- University of Virginia
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- May 1, 2025
- Completion date
- December 31, 2027
- Enrollment
- 6 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.